b3gat1l Literature

Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.

Gene Literature (40)

XB--5956385

Papers associated with b3gat1l (and Disease Ontology)

???pagination.result.count???

???pagination.result.page??? 1

Sort Newest To Oldest	Sort Oldest To Newest

Sort Newest To Oldest

Sort Oldest To Newest

	Targeting TMEM176B Enhances Antitumor Immunity and Augments the Efficacy of Immune Checkpoint Blockers by Unleashing Inflammasome Activation., Segovia M, Russo S, Jeldres M, Mahmoud YD, Perez V, Duhalde M, Charnet P, Rousset M, Victoria S, Veigas F, Louvet C, Vanhove B, Floto RA, Anegon I, Cuturi MC, Girotti MR, Rabinovich GA, Hill M., Cancer Cell. May 13, 2019; 35 (5): 767-781.e6.

Targeting TMEM176B Enhances Antitumor Immunity and Augments the Efficacy of Immune Checkpoint Blockers by Unleashing Inflammasome Activation., Segovia M, Russo S, Jeldres M, Mahmoud YD, Perez V, Duhalde M, Charnet P, Rousset M, Victoria S, Veigas F, Louvet C, Vanhove B, Floto RA, Anegon I, Cuturi MC, Girotti MR, Rabinovich GA, Hill M., Cancer Cell. May 13, 2019; 35 (5): 767-781.e6.

???pagination.result.page??? 1

???displayGene.coCitedPapers???
Show all b3gat1l papers